In yesterday’s Wall Street session, Gilead Sciences, Inc (NASDAQ:GILD) shares traded at $103.31, up 7.46% from the previous session.
GILD stock price is now 10.56% away from the 50-day moving average and 27.65% away from the 200-day moving average. The market capitalization of the company currently stands at $128.75B.
With the price target enhanced from $87 to $113, Morgan Stanley Upgraded its rating from Equal-Weight to Overweight for Gilead Sciences, Inc (NASDAQ: GILD). , while ‘Wolfe Research’ rates the stock as ‘Outperform’
In other news, ANDREW DICKINSON, Officer bought 137,676 shares of the company’s stock on Feb 12 ’25. The stock was bought for $14,073,241 at an average price of $102.22. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 31 ’25, Chief Financial Officer Dickinson Andrew D sold 142,180 shares of the business’s stock. A total of $13,822,740 was realized by selling the stock at an average price of $97.22. This leaves the insider owning 129,873 shares of the company worth $13.42 million. A total of 0.30% of the company’s stock is owned by insiders.
During the past 12 months, Gilead Sciences, Inc has had a low of $62.07 and a high of $100.51. As of last week, the company has a debt-to-equity ratio of 1.21, a current ratio of 1.50, and a quick ratio of 1.20. According to the stock market information, the enterprise value for the company is $136283996160, which is based on a 278.54 price-to-earnings ratio, a 12.16 price-to-earnings-growth ratio, and a beta of 0.27. The fifty day moving average price for GILD is $93.2248 and a two-hundred day moving average price translates $80.74345 for the stock.
The latest earnings results from Gilead Sciences, Inc (NASDAQ: GILD) was released for 2024-09-30. The net profit margin was 1.67% and return on equity was 2.28% for GILD. The company reported revenue of $7.54 billion for the quarter, compared to $7.05 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.01 percent. For the current quarter, analysts expect GILD to generate $6.77B in revenue.
